Kinari Oolong (Camellia sinensis)

Kinari Oolong is a specific cultivar of Camellia sinensis processed as a partially oxidized tea, containing catechins, theaflavins, and caffeine as primary bioactive compounds. No cultivar-specific clinical research exists, so any mechanistic effects derive from general Camellia sinensis phytochemistry rather than evidence tied to this variety.

Origin & History

Kinari Oolong is a tea cultivar variant of Camellia sinensis, with limited documentation showing it comes from tea trees in Laos grown in biodiverse cultivation environments. The specific processing methods and characteristics of this particular oolong variant are not detailed in available research.

Historical & Cultural Context

While the research mentions this tea comes from Laos with biodiverse cultivation, no specific traditional uses or cultural significance are documented. Historical context and traditional preparation methods remain unverified in peer-reviewed sources.

Health Benefits

• No specific clinical benefits documented for Kinari Oolong cultivar - research insufficient
• General Camellia sinensis benefits cannot be extrapolated to this specific variant without evidence
• No controlled trials or observational studies found for this cultivar
• Traditional use claims lack published documentation
• Evidence quality: None - no peer-reviewed studies available

How It Works

Like other Camellia sinensis cultivars, Kinari Oolong likely contains EGCG (epigallocatechin gallate), which inhibits catechol-O-methyltransferase (COMT) and modulates PI3K/Akt signaling pathways. Caffeine acts as an adenosine receptor antagonist (A1 and A2A subtypes), contributing to alertness and thermogenesis. Partial oxidation during oolong processing converts some catechins into theaflavins and thearubigins, which may interact differently with NF-κB inflammatory pathways compared to green tea, though this has not been studied in the Kinari cultivar specifically.

Scientific Research

No clinical trials, meta-analyses, or scientific studies were found in the research dossier for Kinari Oolong specifically. The available information only confirms Camellia sinensis as the parent species and mentions cultivation in Laos without any clinical evidence or PMIDs.

Clinical Summary

No controlled trials, cohort studies, or observational studies have been conducted specifically on the Kinari Oolong cultivar. General oolong tea research—such as a 2003 RCT by Rumpler et al. (n=12) showing a 2.9% increase in 24-hour energy expenditure—cannot be extrapolated to this specific cultivar without independent verification. The phytochemical profile of Kinari Oolong, including its precise catechin-to-theaflavin ratio, has not been publicly characterized in peer-reviewed literature. Evidence strength for any health claim specific to this cultivar is currently rated as insufficient.

Nutritional Profile

{"macronutrients": {"protein": "0.2 g per 100 ml brewed tea", "fiber": "Negligible in brewed tea"}, "micronutrients": {"vitamin_c": "Trace amounts", "potassium": "20 mg per 100 ml brewed tea", "magnesium": "2 mg per 100 ml brewed tea"}, "bioactive_compounds": {"catechins": "30-50 mg per 100 ml brewed tea", "caffeine": "12-30 mg per 100 ml brewed tea", "theanine": "6 mg per 100 ml brewed tea"}, "bioavailability_notes": "Bioactive compounds like catechins and theanine are more bioavailable when consumed with food. Caffeine absorption can vary based on individual metabolism."}

Preparation & Dosage

No clinically studied dosage ranges available for Kinari Oolong. Without published research, safe and effective dosing cannot be determined. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Cannot recommend synergistic ingredients without evidence

Safety & Interactions

Based on its Camellia sinensis origin, Kinari Oolong likely carries caffeine-related risks including elevated heart rate, insomnia, and anxiety at high consumption levels (typically above 400 mg caffeine/day in adults). EGCG at supplemental doses (above 800 mg/day) has been associated with hepatotoxicity in case reports, though brewed tea doses are generally well below this threshold. Potential drug interactions include reduced absorption of non-heme iron, potentiation of stimulant medications, and possible interference with anticoagulants like warfarin due to vitamin K content in tea leaves. Pregnant individuals are advised to limit caffeine intake to under 200 mg/day per ACOG guidelines, which applies to all caffeinated Camellia sinensis preparations.